Chandra and colleagues embarked on a study to explore the impact of extra‐tumoral IL‐17A/IL‐17RA signaling on the growth of pancreatic tumors, leading to the observation of unexpected outcomes associated with IL‐17RA deficiency. Here, IL17A is linked to pancreatic neoplasm.